無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子検査用コントロール (精度管理物質) の世界市場の分析・予測 (〜2024年):非依存性コントロール・装置専用コントロール (DNAシーケンシングなど)

Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 787040
出版日 ページ情報 英文 126 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.33円で換算しております。
Back to Top
分子検査用コントロール (精度管理物質) の世界市場の分析・予測 (〜2024年):非依存性コントロール・装置専用コントロール (DNAシーケンシングなど) Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024
出版日: 2019年02月07日 ページ情報: 英文 126 Pages
概要

分子検査用コントロール (精度管理物質) の市場は予測期間中10.2%のCAGR (年間複合成長率) で推移し、2018年の1億3200万米ドルから、2024年には2億3700万米ドルの規模に成長すると予測されています。サードパーティ精度管理物質の導入拡大、認定臨床ラボ数の増加、外部精度管理支援への需要の拡大などの要因が同市場の成長を推進しています。しかし一方で、プロセスの高コスト性、病院・ラボの予算上の制約、分子検査に対する不利な償還シナリオなどの要因が同市場のさらなる成長の障壁となっています。

当レポートでは、世界の分子検査用コントロール (精度管理物質) の市場を調査し、市場および製品の概要、市場成長への各種影響因子および市場機会の分析、製品タイプ・分析対象区分・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 分子検査用コントロール市場の分析・予測:製品タイプ別

  • イントロダクション
  • 非依存性コントロール
  • 機器専用コントロール
    • PCR
    • DNAシーケンシング&NGS
    • その他

第7章 分子検査用コントロール市場の分析・予測:分析対象別

  • イントロダクション
  • 単独対象
  • 複数対象

第8章 分子検査用コントロール市場の分析・予測:用途別

  • イントロダクション
  • 感染症
  • 遺伝子検査
  • その他

第9章 分子検査用コントロール市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 臨床ラボ
  • 病院
  • IVD製造業者・CRO
  • 学術&研究機関
  • その他

第10章 分子検査用コントロール市場の分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合環境

  • 市場概要
  • 市場ランキング
  • 競合ベンチマーキング
    • 製品ポートフォリオ
    • 事業戦略

第12章 企業プロファイル

  • SERACARE LIFE SCIENCES INC.
  • THERMO FISHER SCIENTIFIC
  • BIO-RAD LABORATORIES
  • MICROBIOLOGICS INC.
  • ZEPTOMETRIX
  • ROCHE DIAGNOSTICS
  • ABBOTT LABORATORIES
  • QUIDEL
  • QNOSTICS
  • MAINE MOLECULAR QUALITY CONTROLS INC.

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 2: INDEPENDENT CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: INDEPENDENT CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 4: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 5: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 6: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 7: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 8: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 9: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 10: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 11: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 12: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 13: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 14: SINGLE-ANALYTE CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: SINGLE-ANALYTE CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 16: MULTI-ANALYTE CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: MULTI-ANALYTE CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 18: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 19: MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 21: MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 23: MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 25: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 27: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 28: MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 30: MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 32: MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 34: MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 36: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 38: MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 45: US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 46: US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 47: US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 48: US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 49: US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 50: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 51: CANADA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 52: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 53: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 54: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 55: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 56: EUROPE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 57: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 58: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 59: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 65: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 66: ROW: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 67: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 68: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 69: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2018 (USD MILLION)
  • FIGURE 7: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2018 VS. 2024 (USD MILLION)
  • FIGURE 8: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2018 (USD MILLION)
  • FIGURE 9: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR QUALITY CONTROLS MARKET
  • FIGURE 11: MOLECULAR QUALITY CONTROLS MARKET TO REGISTER A DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 12: INDEPENDENT CONTROLS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2024)
  • FIGURE 13: CLINICAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MOLECULAR QUALITY CONTROLS MARKET IN 2018
  • FIGURE 14: MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NUMBER OF LABORATORIES THAT RECEIVED CLIA ACCREDITATION, BY ACCREDITATION ORGANIZATION (2018)
  • FIGURE 16: GEOGRAPHIC SNAPSHOT: APAC WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR QUALITY CONTROLS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 18: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 19: RANK OF COMPANIES IN THE GLOBAL MOLECULAR QUALITY CONTROLS MARKET, 2017
  • FIGURE 20: MOLECULAR QUALITY CONTROLS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 21: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 22: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 23: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2017)
  • FIGURE 24: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 25: QUIDEL: COMPANY SNAPSHOT (2017)
目次
Product Code: MD 6900

"The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market."

The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.

"The infectious diseases segment held the largest share of the molecular controls market in 2018."

Based on application, the molecular controls market is divided into four major segments-infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018. The large share of this segment is attributed to the development of advanced assays for different infectious diseases, significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.

"Asia Pacific projected to grow at the highest CAGR during the forecast period."

The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the molecular quality controls market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, analyte type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS COVERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.3.1.1. Key industry insights

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR QUALITY CONTROLS: MARKET OVERVIEW
  • 4.2. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
  • 4.3. NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER (2018)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DRIVERS
      • 5.1.1.1. Increasing number of accredited clinical laboratories
      • 5.1.1.2. Growing adoption of third-party quality controls
      • 5.1.1.3. Rising demand for external quality assessment support
    • 5.1.2. RESTRAINTS
      • 5.1.2.1. Additional costs involved in quality control and budget constraints in hospitals and laboratories
      • 5.1.2.2. Unfavorable reimbursement scenario for molecular tests
    • 5.1.3. OPPORTUNITIES
      • 5.1.3.1. Rising demand for multi-analyte controls
    • 5.1.4. CHALLENGES
      • 5.1.4.1. Lack of mandatory regulations for clinical laboratory accreditation in several emerging countries
      • 5.1.4.2. Complex regulatory frameworks

6. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. INDEPENDENT CONTROLS
    • 6.2.1. WIDE RANGE OF APPLICATIONS AND REDUCTIONS IN OPERATIONAL COSTS HAVE BOOSTED THE USE OF INDEPENDENT CONTROLS
  • 6.3. INSTRUMENT-SPECIFIC CONTROLS
    • 6.3.1. PCR
      • 6.3.1.1. PCR controls dominate the instrument-specific controls market
    • 6.3.2. DNA SEQUENCING & NGS
      • 6.3.2.1. Advancements in sequencing technologies form a positive growth factor for this market
    • 6.3.3. OTHER TECHNOLOGIES

7. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE

  • 7.1. INTRODUCTION
  • 7.2. SINGLE-ANALYTE CONTROLS
    • 7.2.1. SIGNIFICANT USE OF SINGLEPLEX ASSAYS IN HOSPITALS-A KEY MARKET DRIVER
  • 7.3. MULTI-ANALYTE CONTROLS
    • 7.3.1. INCREASING PREFERENCE FOR MULTI-ANALYTE CONTROLS TO FUEL MARKET GROWTH

8. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. INFECTIOUS DISEASES
    • 8.2.1. DEMAND FOR INFECTIOUS DISEASE TESTING CONTROLS HAS GROWN STEADILY
  • 8.3. ONCOLOGY
    • 8.3.1. GROWING CANCER PREVALENCE AND TECHNOLOGICAL ADVANCEMENTS ARE KEY GROWTH DRIVERS IN THIS SEGMENT
  • 8.4. GENETIC TESTING
    • 8.4.1. ADVANCEMENTS IN GENETIC TESTING DRIVE THE MARKET
  • 8.5. OTHER APPLICATIONS

9. MOLECULAR QUALITY CONTROLS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL LABORATORIES
    • 9.2.1. INCREASING NUMBER OF ACCREDITED CLINICAL LABORATORIES TO PROVIDE GROWTH OPPORTUNITIES IN THE COMING YEARS
  • 9.3. HOSPITALS
    • 9.3.1. GROWING PATIENT VOLUME DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS IN HOSPITAL-BASED LABORATORIES
  • 9.4. IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
    • 9.4.1. ADVANCEMENTS IN MOLECULAR TECHNOLOGIES DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS AMONG IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
  • 9.5. ACADEMIC & RESEARCH INSTITUTES
    • 9.5.1. INCREASING DEMAND FOR ENSURING THE ACCURACY OF DIAGNOSTIC TESTS TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT
  • 9.6. OTHER END USERS

10. MOLECULAR QUALITY CONTROLS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Increasing CLIA accreditation for clinical laboratories driving the market for molecular quality controls in the US
    • 10.2.2. CANADA
      • 10.2.2.1. Government investments supporting the development of advanced diagnostic procedures for infectious diseases and cancer in Canada
  • 10.3. EUROPE
    • 10.3.1. GROWING DEMAND FOR EXTERNAL QUALITY CONTROL SUPPORT FROM END USERS WILL PROVIDE GROWTH OPPORTUNITIES
  • 10.4. ASIA PACIFIC
    • 10.4.1. STRATEGIC DEVELOPMENTS BY LEADING PLAYERS TO DRIVE THE MARKET FOR MOLECULAR QUALITY CONTROLS IN APAC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. MARKET OVERVIEW
  • 11.2. MARKET RANKING ANALYSIS, 2017
    • 11.2.1. COMPETITIVE LEADERSHIP MAPPING
    • 11.2.2. VISIONARY LEADERS
    • 11.2.3. INNOVATORS
    • 11.2.4. DYNAMIC DIFFERENTIATORS
    • 11.2.5. EMERGING COMPANIES
  • 11.3. COMPETITIVE BENCHMARKING
    • 11.3.1. STRENGTH OF PRODUCT PORTFOLIO (15 PLAYERS)
    • 11.3.2. BUSINESS STRATEGY EXCELLENCE (15 PLAYERS)

12. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 12.1. SERACARE LIFE SCIENCES INC.
  • 12.2. THERMO FISHER SCIENTIFIC
  • 12.3. BIO-RAD LABORATORIES
  • 12.4. MICROBIOLOGICS INC.
  • 12.5. ZEPTOMETRIX
  • 12.6. ROCHE DIAGNOSTICS
  • 12.7. ABBOTT LABORATORIES
  • 12.8. QUIDEL
  • 12.9. QNOSTICS
  • 12.10. MAINE MOLECULAR QUALITY CONTROLS INC.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS
Back to Top